Cornell University;TRI-Institutional Therapeutics Discovery Institute
发明人:
申请号：
EP18866475.9
公开号：
EP3694508A1
申请日:
2018.10.11
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The compounds of the present invention are represented by the following compounds having Formula I and Formula (I'): where the substituents R1, R2, R2', R3, R4, R5, R', R", X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R', R", X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.
